Individual provider · Type 1 NPI
Shields Brewster Abernathy, MD
Allergy & Immunology (Internal Medicine) Physician · Templeton, CA
Practice location
1050 Las Tablas Rd, Suite 3
Templeton, CA 93465-9729
Fax (805) 434-3265
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Allergy & Immunology (Internal Medicine) Physician Primary | 207RA0201X | G42752 (CA) |
Allergy & Immunology (Internal Medicine) Physician: An internist doctor of osteopathy that specializes in the treatment of allergy and immunologic disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine can obtain a Certificate of Special Qualifications in the field of Allergy & Immunology.
16 other providers at this address
- California Retina ConsultantsRetina Specialist (Ophthalmology) Physician Templeton, CA NPI 1134399462
- Central Coast Vision and LearningVision Therapy Optometrist Templeton, CA NPI 1477007235
- Ear Nose and Throat Medical Clinic IncOtolaryngic Allergy Physician Templeton, CA NPI 1043212376
- Nova Labs, LLCClinical Medical Laboratory Templeton, CA NPI 1437509858
- Templeton Gynecology, Inc.Gynecology Physician Templeton, CA NPI 1518163906
- Templeton Hills PharmacyCommunity/Retail Pharmacy Templeton, CA NPI 1881765899
- Templeton Institute for Neurology IncNeurology Physician Templeton, CA NPI 1356673602
- Amr Al-Hariri, MDNeurology Physician Templeton, CA NPI 1497862254
- Debra A. Turull, DOGynecology Physician Templeton, CA NPI 1467403519
- Faith Marie Frankel, MDFamily Medicine Physician Templeton, CA NPI 1467737205
- Janice C. Ortiz-Singh, MDFamily Medicine Physician Templeton, CA NPI 1679524854
- Janice Johnson, RDHDental Hygienist Templeton, CA NPI 1548447733
About NPI 1508886235
Shields Brewster Abernathy, MD's National Provider Identifier is 1508886235, issued on Jul 19, 2006. The primary taxonomy on file is Allergy & Immunology (Internal Medicine) Physician (207RA0201X), and the practice location is in Templeton, CA. The record was last updated on Mar 21, 2017.